According to the sources, the FDA launched the inspection at the company's facilities in Songdo, west of Seoul, and is ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA ...

Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Cell division is an essential biological process that removes aged cells and continuously renews tissues. In the human body, billions of cells divide each day: intestinal cells are completely renewed ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...